Sophia Randolph Alx Oncology Holdings Inc (ALXO) insider trading activity

ALXO Quotes by TradingView

Sophia Randolph is CHIEF MEDICAL OFFICER of ALX ONCOLOGY HOLDINGS INC. Currently has a direct ownership of 325,711 shares of ALXO, which is worth approximately $465,766. The most recent transaction as insider was on Aug 14, 2024, when has been sold 1,365 shares (Common Stock) at a price of $2.58 per share, resulting in proceeds of $3,521. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 326K
0.42% 3M change
3.24% 12M change
Total Value Held $465,766

Sophia Randolph Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 14 2024
SELL
Open market or private sale
$3,521 $2.58 p/Share
1,365 Reduced 0.42%
325,711 Common Stock
Jul 01 2024
SELL
Open market or private sale
$19,048 $5.82 p/Share
3,273 Reduced 0.99%
327,076 Common Stock
May 13 2024
SELL
Open market or private sale
$195,000 $16.25 p/Share
12,000 Reduced 3.51%
330,349 Common Stock
Feb 14 2024
BUY
Grant, award, or other acquisition
-
30,000 Added 8.06%
342,349 Common Stock
Dec 29 2023
SELL
Open market or private sale
$47,045 $15.04 p/Share
3,128 Reduced 0.99%
312,349 Common Stock
Jul 25 2023
BUY
Grant, award, or other acquisition
-
34,000 Added 9.73%
315,477 Common Stock
Jun 30 2023
SELL
Open market or private sale
$11,780 $7.34 p/Share
1,605 Reduced 0.57%
281,477 Common Stock
Jun 09 2023
BUY
Exercise of conversion of derivative security
$46,184 $3.6 p/Share
12,829 Added 4.34%
283,082 Common Stock
Dec 29 2022
SELL
Open market or private sale
$17,900 $11.07 p/Share
1,617 Reduced 0.59%
270,253 Common Stock
Dec 16 2022
BUY
Exercise of conversion of derivative security
$167,306 $3.6 p/Share
46,474 Added 14.6%
271,870 Common Stock
Aug 05 2022
BUY
Grant, award, or other acquisition
-
37,000 Added 14.1%
225,396 Common Stock
Dec 15 2021
BUY
Exercise of conversion of derivative security
$34,585 $1.45 p/Share
23,852 Added 11.24%
188,396 Common Stock
Nov 22 2021
SELL
Open market or private sale
$547,285 $36.77 p/Share
14,884 Reduced 8.3%
164,544 Common Stock
Nov 22 2021
BUY
Exercise of conversion of derivative security
$122,400 $4.08 p/Share
30,000 Added 14.32%
179,428 Common Stock
Oct 11 2021
SELL
Open market or private sale
$451,198 $61.08 p/Share
7,387 Reduced 4.71%
149,428 Common Stock
Sep 10 2021
SELL
Open market or private sale
$572,345 $77.48 p/Share
7,387 Reduced 4.5%
156,815 Common Stock
Aug 10 2021
SELL
Open market or private sale
$478,751 $64.81 p/Share
7,387 Reduced 4.31%
164,202 Common Stock
Jul 12 2021
SELL
Open market or private sale
$408,944 $55.36 p/Share
7,387 Reduced 4.13%
171,589 Common Stock
Jun 10 2021
SELL
Open market or private sale
$448,686 $60.74 p/Share
7,387 Reduced 3.96%
178,976 Common Stock
May 10 2021
SELL
Open market or private sale
$462,796 $62.65 p/Share
7,387 Reduced 3.81%
186,363 Common Stock
Apr 12 2021
SELL
Open market or private sale
$447,061 $60.52 p/Share
7,387 Reduced 3.67%
193,750 Common Stock
Mar 10 2021
SELL
Open market or private sale
$553,286 $74.9 p/Share
7,387 Reduced 3.54%
201,137 Common Stock
SR

Sophia Randolph

CHIEF MEDICAL OFFICER
South San Francisco, CA

Track Institutional and Insider Activities on ALXO

Follow ALX ONCOLOGY HOLDINGS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALXO shares.

Notify only if

Insider Trading

Get notified when an Alx Oncology Holdings Inc insider buys or sells ALXO shares.

Notify only if

News

Receive news related to ALX ONCOLOGY HOLDINGS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALXO